Pregnancy Outcomes Following Maternal Exposure to Pramipexole: A TERAFAR Case Series

IF 2 4区 医学 Q4 DEVELOPMENTAL BIOLOGY
Deniz Ceyda Bakirli, Ersan Horoz, Cagri Caglayan Kuragi, Mesut Gungor, Osman Karakulak, Tijen Kaya Temiz, Baris Karadas, Ismail Yilmaz, Yusuf Cem Kaplan
{"title":"Pregnancy Outcomes Following Maternal Exposure to Pramipexole: A TERAFAR Case Series","authors":"Deniz Ceyda Bakirli,&nbsp;Ersan Horoz,&nbsp;Cagri Caglayan Kuragi,&nbsp;Mesut Gungor,&nbsp;Osman Karakulak,&nbsp;Tijen Kaya Temiz,&nbsp;Baris Karadas,&nbsp;Ismail Yilmaz,&nbsp;Yusuf Cem Kaplan","doi":"10.1002/bdr2.70126","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>To evaluate pregnancy outcomes following maternal pramipexole exposure using data from the Izmir Kâtip Celebi University Teratology Information, Training and Research Center (TERAFAR).</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Pregnant women exposed to pramipexole and referred to the TERAFAR between 2011 and 2025 were evaluated. Maternal demographic data, medical history, and exposure details were recorded at the initial visit; pregnancy outcomes and neonatal data were collected through postpartum telephone interviews. The primary outcome was the rate of major congenital malformations, while secondary outcomes included miscarriage, stillbirth, preterm birth, and low birth weight.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>A total of 11 pregnancies were evaluated. Median maternal age was 36 years, and restless legs syndrome was the primary indication in 10 of the 11 pregnancies. The median daily dose was 0.25 mg. Of the 11 pregnancies, 10 resulted in live births and one ended in miscarriage. No major congenital malformations were observed. A minor congenital anomaly (infantile hemangioma) was detected in only one premature infant.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>In this case series, maternal exposure to pramipexole was not associated with a consistent pattern of congenital anomalies suggestive of a teratogenic signal. Given the clinical context, the minor anomaly observed (infantile hemangioma) is more likely attributable to prematurity and maternal factors than to pramipexole exposure. Given the small sample size, findings should be interpreted with caution but may inform individualized counseling of pregnant women with inadvertent pramipexole exposure. Further studies are warranted.</p>\n </section>\n </div>","PeriodicalId":9121,"journal":{"name":"Birth Defects Research","volume":"118 11","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Birth Defects Research","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/bdr2.70126","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"DEVELOPMENTAL BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

To evaluate pregnancy outcomes following maternal pramipexole exposure using data from the Izmir Kâtip Celebi University Teratology Information, Training and Research Center (TERAFAR).

Methods

Pregnant women exposed to pramipexole and referred to the TERAFAR between 2011 and 2025 were evaluated. Maternal demographic data, medical history, and exposure details were recorded at the initial visit; pregnancy outcomes and neonatal data were collected through postpartum telephone interviews. The primary outcome was the rate of major congenital malformations, while secondary outcomes included miscarriage, stillbirth, preterm birth, and low birth weight.

Results

A total of 11 pregnancies were evaluated. Median maternal age was 36 years, and restless legs syndrome was the primary indication in 10 of the 11 pregnancies. The median daily dose was 0.25 mg. Of the 11 pregnancies, 10 resulted in live births and one ended in miscarriage. No major congenital malformations were observed. A minor congenital anomaly (infantile hemangioma) was detected in only one premature infant.

Conclusions

In this case series, maternal exposure to pramipexole was not associated with a consistent pattern of congenital anomalies suggestive of a teratogenic signal. Given the clinical context, the minor anomaly observed (infantile hemangioma) is more likely attributable to prematurity and maternal factors than to pramipexole exposure. Given the small sample size, findings should be interpreted with caution but may inform individualized counseling of pregnant women with inadvertent pramipexole exposure. Further studies are warranted.

孕妇暴露于普拉克索后的妊娠结局:TERAFAR病例系列
利用Izmir ktip Celebi大学畸胎学信息、培训和研究中心(TERAFAR)的数据评估孕妇接触普拉克索后的妊娠结局。方法对2011 ~ 2025年暴露于普拉克索并参照TERAFAR的孕妇进行评价。在初次就诊时记录产妇人口统计数据、病史和暴露细节;通过产后电话访谈收集妊娠结局和新生儿数据。主要结局是主要先天性畸形的发生率,而次要结局包括流产、死产、早产和低出生体重。结果共对11例妊娠进行评估。产妇年龄中位数为36岁,不宁腿综合征是11例妊娠中10例的主要指征。中位日剂量为0.25 mg。在11例怀孕中,10例活产,1例流产。未见重大先天性畸形。一个轻微的先天性异常(婴儿血管瘤)被发现只有一个早产儿。结论:在本病例系列中,母体暴露于普拉克索与提示致畸信号的先天性异常的一致模式无关。鉴于临床背景,观察到的轻微异常(婴儿血管瘤)更可能归因于早产和母亲因素,而不是普拉克索暴露。鉴于样本量小,研究结果应谨慎解释,但可能为无意中暴露于普拉克索的孕妇提供个性化咨询。进一步的研究是必要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Birth Defects Research
Birth Defects Research Medicine-Embryology
CiteScore
3.60
自引率
9.50%
发文量
153
期刊介绍: The journal Birth Defects Research publishes original research and reviews in areas related to the etiology of adverse developmental and reproductive outcome. In particular the journal is devoted to the publication of original scientific research that contributes to the understanding of the biology of embryonic development and the prenatal causative factors and mechanisms leading to adverse pregnancy outcomes, namely structural and functional birth defects, pregnancy loss, postnatal functional defects in the human population, and to the identification of prenatal factors and biological mechanisms that reduce these risks. Adverse reproductive and developmental outcomes may have genetic, environmental, nutritional or epigenetic causes. Accordingly, the journal Birth Defects Research takes an integrated, multidisciplinary approach in its organization and publication strategy. The journal Birth Defects Research contains separate sections for clinical and molecular teratology, developmental and reproductive toxicology, and reviews in developmental biology to acknowledge and accommodate the integrative nature of research in this field. Each section has a dedicated editor who is a leader in his/her field and who has full editorial authority in his/her area.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书